Morningstar
•
Aug 06, 2026
McKesson Corporation: McKesson Earnings: Raising Our Fair Value After Fundamental Strength Exceeds Expectations
Summary
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Technical Assessment: Bullish in the Intermediate-Term
Sep 03, 2026
•
HUM, FCX
Analyst Report: Cencora, Inc.
Sep 02, 2026
•
COR
CI: Raising target price to $311.00
Sep 02, 2026
•
CI
DVA: Lowering target price to $185.00
Sep 02, 2026
•
DVA
HSIC: Lowering target price to $93.00
Sep 02, 2026
•
HSIC
